Literature DB >> 29189303

Biomarkers of Cognitive Impairment: Brain Cortical Thickness, Volumetrics, and Cerebrospinal Fluid.

Ladan Ghazi-Saidi1, Ryan R Walsh2, Guogen Shan3,4, Sarah J Banks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29189303      PMCID： PMC5957760          DOI： 10.1097/WAD.0000000000000226

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN： 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  10 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Neuropsychological and behavioural correlates of CSF biomarkers in dementia.

Authors:  Sebastiaan Engelborghs; Karen Maertens; Ellen Vloeberghs; Tony Aerts; Nore Somers; Peter Mariën; Peter P De Deyn
Journal:  Neurochem Int       Date:  2006-01-24       Impact factor: 3.921

Review 3.  The clinical use of structural MRI in Alzheimer disease.

Authors:  Giovanni B Frisoni; Nick C Fox; Clifford R Jack; Philip Scheltens; Paul M Thompson
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

4.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

Review 5.  CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.

Authors:  Simone Lista; Francesco G Garaci; Michael Ewers; Stefan Teipel; Henrik Zetterberg; Kaj Blennow; Harald Hampel
Journal:  Alzheimers Dement       Date:  2013-07-11       Impact factor: 21.566

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.

Authors:  Angela L Guillozet; Sandra Weintraub; Deborah C Mash; M Marsel Mesulam
Journal:  Arch Neurol       Date:  2003-05

Review 8.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Li Shen; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2013-08-07       Impact factor: 21.566

9.  Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion.

Authors:  Eric Westman; J-Sebastian Muehlboeck; Andrew Simmons
Journal:  Neuroimage       Date:  2012-05-03       Impact factor: 6.556

Review 10.  Brain atrophy in Alzheimer's Disease and aging.

Authors:  Lorenzo Pini; Michela Pievani; Martina Bocchetta; Daniele Altomare; Paolo Bosco; Enrica Cavedo; Samantha Galluzzi; Moira Marizzoni; Giovanni B Frisoni
Journal:  Ageing Res Rev       Date:  2016-01-28       Impact factor: 10.895
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.